PD-1-Targeted IL-2v Expands a Novel Stem-like T Cell Subset Distinct from Anti-PD-1 Therapy to Enhance Effector Differentiation
Elzbieta Gralinska, Caterina Scirgolea, Amrita Manchala, Maria Karagianni, Greta Durini, Tamara Hüsser, Emilio Yángüez, Valeria Nicolini, Said Aktas, Laura Codarri Deak
This study shows PD1-IL2v expands a novel stem-like T cell subset in lymph nodes that enhances effector differentiation, distinct from PD-1 therapy's exhausted state.
bioRxiv · Aug 20, 2026 · PreprintImmunology